Medical Center

UCI to take part in clinical trial of drug for critically ill COVID-19 patients

Orange, Calif., May 13, 2020 — UCI Health will initiate a clinical study of a drug to treat critically ill COVID-19 patients who face a high mortality rate because of acute inflammation that fills their lungs with fluid, a grave condition that even mechanical ventilation cannot improve. Aviptadil, which has a 20-year history of use in human clinical trials for lung ailments, will be employed in a phase 2b/3 clinical study of COVID-19 patients suffering from acute respiratory distress syndrome, a primary cause of coronavirus-induced death, said Dr.

Tu Foundation gives $2.5 million to UCI to support COVID-19 patient care, research

Irvine, Calif., May 11, 2020 — A $2.5 million gift from the John and Mary Tu Foundation to the University of California, Irvine is supporting COVID-19-associated patient care at UCI Health and advance clinical and translational research across campus focused on new ways to test for and treat the viral infection. As the region’s only combined academic health system and public research university, UCI is at the forefront in galvanizing an active response to the pandemic.

Chad T. Lefteris named CEO of UCI Health

Irvine, Calif., April 2, 2020 — Chad T. Lefteris, an executive with considerable experience in integrated and academic health systems, has been named CEO of UCI Health, overseeing Orange County’s only academic medical center and all clinical and patient-serving operations. His appointment was approved by the University of California Board of Regents.